KARBE FRANK purchased 28.1% of their position (12.50K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $99.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/16/2024ACC: 0000950170-24-136391
+12.50K
Net shares
Net buyer
$99.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$7.93
Trade value
$99.08K
% of position
28.1%
12/13/2024
44.50K→57K
Total
Net shares
+12.50K
Net value
$99.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2024 | P · Purchase | +12.50K | $7.93 | $99.08K | 28.1% | 44.50K | 57K |
| Total | +12.50K | $99.08K | ||||||
Derivative Transactions0
No derivative transactions reported